Bausch + Lomb Corporation

BLCO·NYSE
Compare
16.07−1.23 (−7.11%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close17.30
Open16.83
Day range15.4716.83
52-week range14.4418.92
Off day high−4.52%
Off 52-week high−15.04%
Volume3.01M
Avg. volume (3M)435.47K
Market cap5.74B
EPS (TTM)-0.5300
Forward P/E14.43
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding357.17M
Short interest—
Earnings dateOct 28, 2026
Analyst target—
Profit margin—

Against its peers

Compare in full ›
BLCO ALC COO STAA WRBY BAX
Market cap 5.74B 31.11B 10.56B 1.10B 3.21B 12.81B
P/E (TTM) — 48.7 19.5 275.1 433.2 —
Forward P/E 14.4 16.2 11.8 19.8 42.3 12.1
Price/book 0.9 1.4 1.3 3.0 8.2 2.1
Dividend yield — 0.56% — — — 0.16%
1-year change +6.21% −13.13% −21.99% −18.78% +13.86% +8.59%
Today −7.11% +0.37% +2.16% +1.57% +2.73% +1.77%

The closest companies by business and industry (Medical Instruments & Supplies). Prices may be delayed up to 15 min.

Latest news

All BLCO news ›
Seeking Alpha·Positive

Bausch + Lomb names Thomas Appio interim CEO, signals guidance hike

Bausch + Lomb names Thomas J. Appio interim CEO as Brent Saunders departs; companies may raise 2026 adjusted EBITDA guidance ahead of Oct. - Bausch + Lomb (BLCO:CA) appointed chairman Thomas J. Appio as interim CEO, effective immediately,…

pharmaphorum·

Brent Saunders ejects from Bausch + Lomb once again

Brent Saunders' second stint as chief executive of eye care company Bausch + Lomb has come to an end. He is stepping down immediately from the role – by mutual agreement with the board of directors – and will be replaced as CEO on an…

@VisionMonday·Positive

Thomas J. Appio Appointed Interim CEO of Bausch + Lomb | VM

VAUGHAN, Ontario—Global eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO), and its parent company, Bausch Health Companies Inc. (NYSE/TSX: BHC), announced this morning that Thomas J. Appio, chairman, Bausch + Lomb board of…

@VisionMonday·Positive

DryEye Rescue Distributes ScoutPro From Bausch + Lomb | VM

BOCA RATON, Fla.—DryEye Rescue, a licensed supplier of over-the-counter and prescription pharmaceuticals to doctors and practices, has announced that it is now the exclusive distributor of ScoutPro in the U.S., with Bausch + Lomb…

From articles in the 4Search news index.

In the news

21mentions in 30 days
21with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 21 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.